Showing results (511-520 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|June 9, 2021
Effects of Lemborexant on the Pharmacokinetics of Oral Contraceptives: Results From a Phase 1 Drug-Drug Interaction Study in Healthy FemalesIshani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Clinical Pharmacology in Drug Development|June 9, 2021
Napabucasin Drug-Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult VolunteersXiaoshu Dai, Michael D Karol, Matthew Hitron, et al.
Clinical Pharmacology in Drug Development|June 9, 2021
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv MecarbilAshit Trivedi, Rajneet K Oberoi, Mia Mackowski, et al.
Clinical Pharmacology in Drug Development|June 9, 2021
Pharmacokinetics and Bioequivalence Study of a New Branded Generic Moxifloxacin Tablet Among Healthy VolunteersAtiqah Amran, Ching Yee Tan, Ka-Liong Tan, et al.
Clinical Pharmacology in Drug Development|June 16, 2021
Effects of Postoperative Day and NR1I2 on Tacrolimus Clearance in Chinese Liver Transplant Recipients-A Population Model ApproachYanxia Lu, Li Xu, Jianrong Cui, et al.
Clinical Pharmacology in Drug Development|October 30, 2020
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of a Respiratory Syncytial Virus Neutralizing Monoclonal Antibody MK-1654 in Healthy AdultsAntonios O Aliprantis, Dennis Wolford, Luzelena Caro, et al.
Clinical Pharmacology in Drug Development|July 5, 2022
Pharmacokinetics of Icosapent Ethyl: An Open-Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese SubjectsFei Yuan, Hui Li, Mengjie Yang, et al.
Clinical Pharmacology in Drug Development|July 21, 2021
Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy ParticipantsHuiping Xu, Melissa T O'Gorman, Sunil Nepal, et al.
Clinical Pharmacology in Drug Development|July 24, 2021
Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy VolunteersYujin Wang, Daria B Crittenden, Clarence Eng, et al.
Clinical Pharmacology in Drug Development|July 17, 2021
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Omeprazole, a Proton Pump Inhibitor, in Healthy SubjectsAshit Trivedi, Winnie Sohn, Pegah Jafarinasabian, et al.
Pageof 136